Labeling Update Claims Survive Dismissal In Fosamax MDL
A New York federal judge ruled Thursday that manufacturers of generic versions of the bone drug Fosamax can be held liable for failing to match their warning labels to the brand-name...To view the full article, register now.
Already a subscriber? Click here to view full article